Welcome to the latest of our Eberhard F Mammen award announcements. As noted previously,[1]
[2]
[3] Thieme, the publisher of Seminars in Thrombosis & Hemostasis (STH), has created the Eberhard F Mammen Excellence in Thrombosis and Hemostasis Awards in honor of Eberhard Mammen ([Fig. 1]) and in recognition of his contribution to this field and to the journal that he
both founded and steered for more than three decades. These awards began in 2009,
under two categories, “Most Popular Article Awards” and “Young Investigator Awards.”
Current details and conditions of the award can be summarized as follows:
Fig. 1 Eberhard F Mammen (1930–2008).
-
Most Popular Article Awards: These are awarded to the authors of the most popular
articles published in STH. The awards are determined by the Editor-in-Chief on the
basis of user statistics from Thieme e-Journals for the preceding 2 years. Prefaces,
Errata, Letters to the Editor, Editorials, and previous award-winning articles are
excluded from further consideration of these awards, which currently comprise two
categories: one for “Open Access” articles and another for a “General Category.” There
are two major cash prizes of US$1,000 for each category. In addition, winners of the
“General Category” awards are granted “open access” status for these articles thereafter.
-
Young Investigator Awards: These are awarded for the best presentation or meeting
abstract by a young investigator, as presented or delivered to an international or
large regional meeting on a topic related to the fields of thrombosis and hemostasis,
and whose subject matter is determined to be in the spirit of Dr. Mammen. There are
up to six cash prizes of US$1,000 in any year. There are some additional considerations
and conditions for the award, and awardees are expected to prepare a review or other
paper related to the topic of their presentation for publication in STH.
Further details of the awards and the award winners are posted online (https://www.thieme-connect.com/products/ejournals/journal/10.1055/s-00000077), and previous award winner announcements are also available in print.[4]
[5]
[6]
[7]
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
It is therefore with great pleasure that we would like to announce the latest winners
of the 2018 Eberhard F Mammen awards for the most popular articles from STH for the
period of 2016 to 2017 inclusive. We will be announcing the Young Investigator Awards
related to meetings held in the recent past at a forthcoming opportunity.
2018 “Most Popular” Article Awards
As mentioned previously, the Most Popular awards are given to the authors of the most
popular articles published in STH as determined on the basis of user statistics from
the publisher of this journal and covering the preceding 2-year period. Thus, the
2018 “Most Popular” awards are granted to the most popular papers from 2016 to 2017
inclusive. Previous Eberhard F Mammen award-winning articles are listed in [Table 1]. These articles are currently available under an “Open Access” status and no longer
qualify for future awards, although many will continue to appear in the most popular
download statistics provided by the publisher. Indeed, not unexpectedly, all previous
award-winning articles made the top 150 list, with most ranking highly and still proving
popular with our readership.
Table 1
Previous most popular award-winning papers
|
Year
|
Awarded for
|
Position in the 2018 list
|
|
2009
|
Jurk K, Kehrel BE. Platelets: physiology and biochemistry. Semin Thromb Hemost 2005;31(4):381–392
|
4
|
|
2009
|
Girolami B, Girolami A. Heparin-induced thrombocytopenia: a review. Semin Thromb Hemost
2006;32(8):803–809
|
44
|
|
2010
|
Harenberg J, Wehling M. Current and future prospects for anticoagulant therapy: inhibitors
of factor Xa and factor IIa. Semin Thromb Hemost 2008;34(1):39–57
|
69
|
|
2010
|
Prechel M, Walenga JM. The laboratory diagnosis and clinical management of patients
with heparin-induced thrombocytopenia: an update. Semin Thromb Hemost 2008;34(1):86–96
|
43
|
|
2010
|
Fareed J, Hoppensteadt DA, Fareed D, Demir M, Wahi R, Clarke M, Adiguzel C, Bick R.
Survival of heparins, oral anticoagulants, and aspirin after the year 2010. Semin
Thromb Hemost 2008;34(1):58–73
|
36
|
|
2011
|
Sobieraj-Teague M, O'Donnell M, Eikelboom J. New anticoagulants for atrial fibrillation.
Semin Thromb Hemost 2009;35(5):515–524
|
56
|
|
2011
|
Mariani G, Bernardi F. Factor VII Deficiency. Semin Thromb Hemost 2009;35(4):400–406
|
8
|
|
2012
|
Lippi G, Franchini M, Favaloro EJ, Targher G. Moderate red wine consumption and cardiovascular
disease risk: beyond the “French paradox.” Semin Thromb Hemost 2010;36(1):59–70
|
3
|
|
2012
|
Rak J. Microparticles in cancer. Semin Thromb Hemost 2010;36(8):888–906
|
9
|
|
2013
|
Fava C, Montagnana M, Favaloro EJ, Guidi GC, Lippi G. Obstructive sleep apnea syndrome
and cardiovascular diseases. Semin Thromb Hemost 2011;37(3):280–297
|
24
|
|
2013
|
Tufano A, Guida A, Dario Di Minno MN, Prisco D, Cerbone AM, Minno GD. Prevention of
venous thromboembolism in medical patients with thrombocytopenia or with platelet
dysfunction: a review of the literature. Semin Thromb Hemost 2011;37(3):267–274
|
7
|
|
2014
|
Salmela B, Joutsi-Korhonen L, Armstrong E, Lassila R. Active online assessment of
patients using new oral anticoagulants: bleeding risk, compliance, and coagulation
analysis. Semin Thromb Hemost 2012;38(1):23–30
|
45
|
|
2014
|
Chapman K, Seldon M, Richards R. Thrombotic microangiopathies, thrombotic thrombocytopenic
purpura, and ADAMTS-13. Semin Thromb Hemost 2012;38(1):47–54
|
10
|
|
2014
|
Kenet G, Aronis S, Berkun Y, Bonduel M, Chan A, Goldenberg NA, Holzhauer S, Iorio
A, Journeycake J, Junker R, Male C, Manco-Johnson M, Massicotte P, Mesters R, Monagle
P, van Ommen H, Rafini L, Simioni P, Young G, Nowak-Göttl U. Impact of persistent
antiphospholipid antibodies on risk of incident symptomatic thromboembolism in children:
a systematic review and meta-analysis. Semin Thromb Hemost 2011;37(7):802–809
|
14
|
|
2015
|
Tapson VF. Thrombolytic therapy for acute pulmonary embolism. Semin Thromb Hemost
2013;39(4):452–458
|
35
|
|
2015
|
George JN, Charania RS. Evaluation of patients with microangiopathic hemolytic anemia
and thrombocytopenia. Semin Thromb Hemost 2013;39(2):153–160
|
6
|
|
2015[a]
|
Hylek EM. Anticoagulation therapy for atrial fibrillation. Semin Thromb Hemost 2013;39(2):147–152
|
48
|
|
2015[a]
|
Rojas-Hernandez CM, Garcia DA. The novel oral anticoagulants. Semin Thromb Hemost
2013;39(2):117–126
|
138
|
|
2016
|
de Moerloose P, Casini A, Neerman-Arbez M. Congenital fibrinogen disorders: an update.
Semin Thromb Hemost 2013;39(6):585–595
|
13
|
|
2016
|
Sethi S, Fervenza FC. Pathology of renal diseases associated with dysfunction of the
alternative pathway of complement: C3 glomerulopathy and atypical hemolytic uremic
syndrome (aHUS). Semin Thromb Hemost 2014;40(4):416–421
|
20
|
|
2016[a]
|
Bates SM. D-dimer assays in diagnosis and management of thrombotic and bleeding disorders.
Semin Thromb Hemost 2012;38(7):673–682
|
26
|
|
2016[a]
|
Lippi G, Favaloro EJ, Meschi T, Mattiuzzi C, Borghi L, Cervellin G. E-cigarettes and
cardiovascular risk: beyond science and mysticism. Semin Thromb Hemost 2014;40(1):60–65
|
2
|
|
2017
|
Boonyawat K, Crowther MA. Venous thromboembolism prophylaxis in critically ill patients.
Semin Thromb Hemost 2015;41(1):68–74
|
62
|
|
2017
|
Levi M, Poll TV. Coagulation in Patients with Severe Sepsis. Semin Thromb Hemost 2015;41(1):9–15
|
75
|
|
2017[a]
|
Moore GW. Recent guidelines and recommendations for laboratory detection of lupus
anticoagulants. Semin Thromb Hemost 2014;40(2):163–171
|
1
|
|
2017[a]
|
Warkentin TE. Heparin-induced thrombocytopenia in critically ill patients. Semin Thromb
Hemost 2015;41(1):49–60
|
11
|
|
2017[b]
|
Favaloro EJ, Lippi G. Laboratory testing in the era of direct or non-vitamin K antagonist
oral anticoagulants: a practical guide to measuring their activity and avoiding diagnostic
errors. Semin Thromb Hemost 2015;41(2):208–227
|
5
|
a New Open Access category.
b This paper qualified as the “Most Popular” award winner based on objective publisher
provided download data; however, as this paper was written by the journal Editor-in-Chief,
there was an obvious conflict of interest, and the award was officially declined.
This paper is listed here merely as a statement of record.
There is also an increasingly recognized trend to publish articles in an open-access
mode, and these have an “inequitable advantage” over other “non-open access” articles
in terms of downloads because of their easy accessibility. Accordingly, the publisher
of STH has established a separate category of the Most Popular Award for “open-access”
papers, to supplement the alternate “General Category,” and thus the most popular
papers are now listed in separate tables. [Table 2] lists the top 20 downloaded open-access articles from STH (2016 and 2017 inclusive),
as eligible for the “Open Access” award.[18]
[19]
[20]
[21]
[22]
[23]
[24]
[25]
[26]
[27]
[28]
[29]
[30]
[31]
[32]
[33]
[34]
[35]
[36]
[37] [Table 3] lists the top 20 downloaded non-open access articles from STH (2016 and 2017 inclusive),
as otherwise eligible for the “General Category” award.[38]
[39]
[40]
[41]
[42]
[43]
[44]
[45]
[46]
[47]
[48]
[49]
[50]
[51]
[52]
[53]
[54]
[55]
[56]
[57]
Table 2
Most popular papers: “Open Access” category[a]
|
Rank
|
Publication
|
|
1
|
Cuker A, Prak ET, Cines DB. Can immune thrombocytopenia be cured with medical therapy?
Semin Thromb Hemost 2015;41(4):395–404
|
|
2
|
Cuker A. Clinical and laboratory diagnosis of heparin-induced thrombocytopenia: an
integrated approach. Semin Thromb Hemost 2014;40(1):106–114
|
|
3
|
Schulman S. Update on the treatment of venous thromboembolism. Semin Thromb Hemost
2016;42(8):891–898
|
|
4
|
Raskob GE, Angchaisuksiri P, Blanco AN, Büller H, Gallus A, Hunt BJ, Hylek EM, Kakkar
TL, Konstantinides SV, McCumber M, Ozaki Y, Wendelboe A, Weitz JI; ISTH Steering Committee
for World Thrombosis Day. Thrombosis: a major contributor to global disease burden.
Semin Thromb Hemost 2014;40(7):724–735
|
|
5
|
Elewa H, Ahmed D, Barnes GD. Triple oral antithrombotic therapy in atrial fibrillation
and coronary artery stenting: searching for the best combination. Semin Thromb Hemost
2016;42(6):662–670
|
|
6
|
Althaus K, Greinacher A. MYH9-related platelet disorders. Semin Thromb Hemost 2009;35(2):189–203
|
|
7
|
Tersteeg C, Fijnheer R, Pasterkamp G, de Groot PG, Vanhoorelbeke K, de Maat S, Maas
C. Keeping von Willebrand factor under control: alternatives for ADAMTS13. Semin Thromb
Hemost 2016;42(1):9–17
|
|
8
|
Favaloro EJ. Clinical utility of the PFA-100. Semin Thromb Hemost 2008;34(8):709–733
|
|
9
|
Demers M, Wagner DD. NETosis: a new factor in tumor progression and cancer-associated
thrombosis. Semin Thromb Hemost 2014;40(3):277–283
|
|
10
|
Mannucci PM, Mancuso ME, Santagostino E, Franchini M. Innovative pharmacological therapies
for the hemophilias not based on deficient factor replacement. Semin Thromb Hemost
2016;42(5):526–532
|
|
11
|
Nurden AT. Platelet membrane glycoproteins: a historical review. Semin Thromb Hemost
2014;40(5):577–584
|
|
12
|
Wada H, Usui M, Sakuragawa N. Hemostatic abnormalities and liver diseases. Semin Thromb
Hemost 2008;34(8):772–778
|
|
13
|
Harenberg J, Du S, Krämer S, Weiss C, Krämer R, Wehling M. Patients' serum and urine
as easily accessible samples for the measurement of non-vitamin K antagonist oral
anticoagulants. Semin Thromb Hemost 2015;41(2):228–236
|
|
14
|
Italiano JE Jr. Unraveling mechanisms that control platelet production. Semin Thromb
Hemost 2013;39(1):15–24
|
|
15
|
Mammen EF. Sticky platelet syndrome. Semin Thromb Hemost 1999;25(4):361–365
|
|
16
|
Zolfaghari S, Harenberg J, Frölich L, Weiss C, Wehling M, Wild P, Prochaska J, Beyer-Westendorf
J, Koscielny J, Lip GY. Development of recommendations to continue anticoagulation
with one of the two types of oral anticoagulants based on the identification of patients'
preference. Semin Thromb Hemost 2015;41(2):166–177
|
|
17
|
Chighizola CB, Raimondo MG, Meroni PL. Management of thrombotic antiphospholipid syndrome.
Semin Thromb Hemost 2017. doi: 10.1055/s-0036-1597282. [e-pub ahead of print] PubMed
PMID: 28278524
|
|
18
|
Harenberg J, Kraemer S, Du S, Giese C, Schulze A, Kraemer R, Weiss C. Determination
of direct oral anticoagulants from human serum samples. Semin Thromb Hemost 2014;40(1):129–134
|
|
19
|
Favaloro EJ, Pasalic L, Curnow J. Type 2M and type 2A von Willebrand disease: similar
but different. Semin Thromb Hemost 2016;42(5):483–497
|
|
20
|
Zolfaghari S, Harenberg J, Froelich L, Wehling M, Weiss C. Development of a tool to
identify patients' preference for vitamin K antagonist or direct oral anticoagulant
therapy. Semin Thromb Hemost 2014;40(1):121–128
|
a 2016 and 2017 inclusive; excludes nonqualifying material (e.g., Prefaces, Errata,
Letters to the Editor, Editorials, and previous award-winning articles).
Table 3
Most popular papers: “General” category[a]
|
Rank
|
Publication
|
|
1
|
Gremmel T, Frelinger AL 3rd, Michelson AD. Platelet physiology. Semin Thromb Hemost
2016;42(3):191–204
|
|
2
|
Mallett SV. Clinical utility of viscoelastic tests of coagulation (TEG/ROTEM) in patients
with liver disease and during liver transplantation. Semin Thromb Hemost 2015;41(5):527–537
|
|
3
|
Kumar R, Dunn A, Carcao M. Changing paradigm of hemophilia management: extended half-life
factor concentrates and gene therapy. Semin Thromb Hemost 2016;42(1):18–29
|
|
4
|
Gando S, Hayakawa M. Pathophysiology of trauma-induced coagulopathy and management
of critical bleeding requiring massive transfusion. Semin Thromb Hemost 2016;42(2):155–165
|
|
5
|
Boccardo P, Remuzzi G, Galbusera M. Platelet dysfunction in renal failure. Semin Thromb
Hemost 2004;30(5):579–589
|
|
6
|
Lassila R. Platelet function tests in bleeding disorders. Semin Thromb Hemost 2016;42(3):185–190
|
|
7
|
Franchini M, Mengoli C, Capuzzo E, Terenziani I, Bonfanti C, Lippi G. Correlation
between ABO blood group, and conventional hematological and metabolic parameters in
blood donors. Semin Thromb Hemost 2016;42(1):75–86
|
|
8
|
McEwen BJ, Morel-Kopp MC, Tofler GH, Ward CM. The effect of omega-3 polyunsaturated
fatty acids on fibrin and thrombin generation in healthy subjects and subjects with
cardiovascular disease. Semin Thromb Hemost 2015;41(3):315–322
|
|
9
|
Schreiber K, Hunt BJ. Pregnancy and antiphospholipid syndrome. Semin Thromb Hemost
2016;42(7):780–788
|
|
10
|
Semeraro N, Ammollo CT, Semeraro F, Colucci M. Coagulopathy of acute sepsis. Semin
Thromb Hemost 2015;41(6):650–658
|
|
11
|
Lordkipanidzé M. Platelet function tests. Semin Thromb Hemost 2016;42(3):258–267
|
|
12
|
Baskurt OK, Meiselman HJ. Blood rheology and hemodynamics. Semin Thromb Hemost 2003;29(5):435–450
|
|
13
|
Scully M. Thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome
microangiopathy in pregnancy. Semin Thromb Hemost 2016;42(7):774–779
|
|
14
|
Curnow J, Pasalic L, Favaloro EJ. Treatment of von Willebrand disease. Semin Thromb
Hemost 2016;42(2):133–146
|
|
15
|
Reynen E, James P. Von Willebrand disease and pregnancy: a review of evidence and
expert opinion. Semin Thromb Hemost 2016;42(7):717–723
|
|
16
|
Riva N, Dentali F, Permunian ET, Ageno W. Major bleeding and case fatality rate with
the direct oral anticoagulants in orthopedic surgery: a systematic review and meta-analysis.
Semin Thromb Hemost 2016;42(1):42–54
|
|
17
|
Ramström S, Södergren AL, Tynngård N, Lindahl TL. Platelet function determined by
flow cytometry: new perspectives? Semin Thromb Hemost 2016;42(3):268–281
|
|
18
|
Scharf RE. Drugs that affect platelet function. Semin Thromb Hemost 2012;38(8):865–883
|
|
19
|
Franchini M, Coppola A, Tagliaferri A, Lippi G. FEIBA versus NovoSeven in hemophilia
patients with inhibitors. Semin Thromb Hemost 2013;39(7):772–778
|
|
20
|
Senoo K, Lip GY. Comparative efficacy and safety of the non-vitamin K antagonist oral
anticoagulants for patients with nonvalvular atrial fibrillation. Semin Thromb Hemost
2015;41(2):146–153
|
a 2016 and 2017 inclusive; excludes nonqualifying material (e.g., Prefaces, Errata,
Letters to the Editor, Editorials, and previous award-winning articles).
Accordingly, the 2017 Eberhard F Mammen award winners for the most popular article
(2016 and 2017 inclusive) are as follows:
It is always interesting to me how some issues, in particular, seem to catch the attention
of the readership. The top-ranking issues this round from the aspect of having four
or more papers in the top 100 download list were: Hot Topics V,[58] Anticoagulant Therapy: Present and Future,[59] Editorial Compilation I,[60] Platelet Function in Thrombosis and Hemostasis,[61] and Controversies in Inherited Bleeding Disorders.[62]
All authors of the award-winning articles were thrilled to hear that their papers
had won an Eberhard F Mammen Most Popular award, and provided the following additional
responses:
From Dr. Adam Cuker ([Fig. 2]): “On behalf of my coauthors, I am truly humbled and delighted to receive not one
but two Eberhard Mammen 2018 Most Popular Article Awards. As with novelists, poets,
and playwrights, we in the biomedical community write in the hopes of reaching and
illuminating our audience and perhaps of moving the needle in our chosen field, if
ever-so-slightly, in the direction of progress. These awards are a vindication of
our work. I am deeply grateful to Seminars in Thrombosis and Hemostasis and to its founding Editor-in-Chief, Eberhard Mammen, for providing a platform for
me to reach my audience.” One of Dr. Cuker's coauthors, Dr. Eline T Luning Prak, also
provided a portrait photo for use in the editorial ([Fig. 3]), but Dr. Douglas B. Cines declined to do so.
Fig. 2 Dr. Adam Cuker.
Fig. 3 Dr. Eline T. Luning Prak.
From Dr. Thomas Gremmel ([Fig. 4]): “I am grateful and truly honored to receive an Eberhard F. Mammen Most Popular
Article Award in 2018 as it reflects the great interest in our work. It is amazing
that our review on Platelet Physiology has already attracted a lot of attention within
the scientific community, and was read and cited by many distinguished colleagues.
I would like to thank my coauthors Alan D. Michelson and Andrew L. Frelinger for their
support in preparing the article, Anne-Mette Hvas for her invitation to contribute
a review article, and the publisher for providing the award. The editors of Seminars in Thrombosis and Hemostasis have to be complimented on their continued selection of very relevant topics for
respective issues of the Journal. As a source of excellent review articles in thrombosis
and hemostasis research, this journal plays a pivotal role in the dissemination of
knowledge in the field. In this regard, I am particularly pleased that our article
will now be given a ‘free access’ status, which will foster its further distribution.”
Both of Dr. Gremmel's coauthors, Drs. Andrew L. Frelinger III and Alan D. Michelson,
also provided portrait photos for use in this editorial ([Figs. 5] and [6]).
Fig. 4 Dr. Thomas Gremmel.
Fig. 5 Dr. Andrew L. Frelinger III.
Fig. 6 Dr. Alan D. Michelson.
From Dr. Susan Mallett ([Fig. 7]): “I was both delighted and surprised to receive the news that my review article
had won a 2018 Eberhard Mammen award for the ‘general’ category. It is indeed a great
honor, and highlights the degree of interest this article has attracted within the
scientific community. It is especially valuable to me personally; as for so many years,
outside of the field of perioperative medicine in which I practice; there has only
been limited interest in the enormous potential of viscoelastic tests to provide clinically
relevant and individualized information about the hemostatic status. Over the last
decade, there has been a paradigm shift in the way coagulation in liver disease is
understood, with much new and exciting work demonstrating that hemostasis is finely,
albeit precariously, ‘re-balanced’ in stable patients with liver disease due to the
multiple and complex changes that occur in the hemostatic system. The many limitations
and inadequacies of conventional coagulation tests in terms of assessing bleeding
and thrombotic risk in patients with liver disease are now recognized. Future research
using global viscoelastic tests will undoubtedly help elucidate some of these risks,
and also give more relevant information that has the potential to eliminate many precautionary
component transfusions that are completely unnecessary. As a consequence, clinical
practice may be significantly altered for the better. I would very much like to thank
Professors Ton Lisman and Hau Kwaan, who guest edited the issue on Hemostatic Dysfunction
in Liver Diseases, for having given me the opportunity to write this review article
for STH.”
Fig. 7 Dr. Susan Mallett.
I must admit to particular joy on this occasion with these announcements. For example,
Dr. Cuker won both awards for the “Open Access” Category. This is a first-time event
in the history of these awards—to have one author win two of the available awards.
Dr. Cuker is a member of the STH editorial board, having been invited to join soon
after he won an earlier (2010) STH Young Investigator Award. Dr. Cuker has contributed
several papers to STH, typically well received by our readership, and most recently
undertook a guest editor role for an issue of STH, shepherding an issue on Clinical
Scoring Systems in Thrombosis and Hemostasis for the journal.[63]
Also interesting is that the issue on platelets[61] was very popular, a finding that may have been predicted by the ongoing presence
of one paper from 2005,[31] a 2009 Most Popular Award winner ([Table 1]), on every annual Most Popular Award announcements.[4]
[6]
[7]
[8]
[9]
[10]
[12]
[14]
[15] I was also very proud to see two giants in the field, Drs. Larry Frelinger and Alan
Michelson, share in a win on this occasion.[38]
Finally, I was particularly proud to see Eberhard F Mammen himself appear on the listing
([Table 2], number 15), for a paper he wrote on “sticky platelet syndrome” and published in
1999.[64] This renewed interest in “sticky platelet syndrome,” one of Eberhard's greatest
interests, may have been spurred by our recent 40th Anniversary celebration of STH
publishing,[65]
[66] as well as more recent papers on the topic,[67]
[68]
[69] in part in tribute to Dr. Mammen.
I would, as always, like to thank not only all of the authors listed in the tables,
but also the contributing authors who did not manage to make these listings, as well
as all the guest editors of issues recently published in STH. I also look forward to seeing future listings—always a great delight and sometimes
quite a surprise.
